Search Results - "Vassallu, P."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Variation of PDGF, TGFβ, and bFGF levels in essential thrombocythemia patients treated with anagrelide

    Variation of PDGF, TGFβ, and bFGF levels in essential thrombocythemia patients treated with anagrelide by Lev, P.R., Marta, R.F., Vassallu, P., Molinas, F.C.

    Published in American journal of hematology (01-06-2002)
    “…We studied 15 patients with essential thrombocythemia (ET) before treatment and after normalization of platelet count by anagrelide. Significantly increased…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations

    Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations by Kornblihtt, L.I, Heller, P.G, Correa, G, Castañón, M, Genoud, V, Vassallu, P, Sarano, J, Kordich, L, Molinas, F.C

    Published in Thrombosis research (2003)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide

    Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide by Lev, P R, Marta, R F, Vassallu, P, Molinas, F C

    Published in American journal of hematology (01-06-2002)
    “…We studied 15 patients with essential thrombocythemia (ET) before treatment and after normalization of platelet count by anagrelide. Significantly increased…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia

    Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia by Marta, R, Goette, N, Lev, P, Heller, P, Kornblihtt, L, Vassallu, P, Glembotsky, A, Pirola, C, Molinas, F

    Published in Haematologica (Roma) (01-06-2004)
    “…Seccion Hematologia Investigacion, Instituto de Investigaciones Medicas Alfredo Lanari, Facultad de Medicina, Universidad de Buenos Aires, Argentina…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis

    Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis by Gargallo, Patricia, Hagemeijer, Anne, Vassallu, Patricia, Kornblihtt, Laura, Heller, Paula, Molinas, Felisa, Larripa, Irene

    Published in Cancer genetics and cytogenetics (01-10-2004)
    “…We report a case of essential thrombocythemia (ET) in a 39-year-old woman who developed myelofibrosis at follow-up. The cytogenetic and fluorescence in situ…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Treatment of essential thrombocythemia with anagrelide: a ten-year experience

    Treatment of essential thrombocythemia with anagrelide: a ten-year experience by Kornblihtt, Laura I, Vassallu, Patricia S, Heller, Paula, Molinas, Felisa C

    Published in Medicina (Buenos Aires) (2002)
    “…Essential thrombocythemia (ET) is a chronic myeloproliferative syndrome characterized by thrombocythemia and increased megakaryocytes in bone marrow,…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: